4-1BB protects dendritic cells from prostate cancer-induced apoptosis

Pathology and Oncology Research

Volumn 19, Issue 2, 2013, Pages 177-181

  Youlin, Kuang ^a   Jianwei, Zhang ^b   Xin, Gou ^a   Li, Zhang ^c   Xiaodong, Weng ^c   Xiuheng, Liu ^c   Hengchen, Zhu ^c   Zhiyuan, Chen ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

4 1BB; Co stimulatory molecules; Dendritic cells; Prostate cancer

Indexed keywords

CD137 ANTIGEN; INTERLEUKIN 12; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4 1BB; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

4-1BB LIGAND; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BCL-X PROTEIN; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; INTERLEUKIN-12; MALE; MICE; MICE, INBRED C57BL; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84880696727     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-012-9566-0     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
2. Kuang Y, Weng X, Liu X et al (2010) Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses. Cancer Lett 293:254-262
3. Lodge PA, Jones LA, Bader RA et al (2000) Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Res 60:829-833
4. Tjoa BA, Simmons SJ, Bowes VA et al (1998) Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate 36:39-44
5. Nencioni A, Grünebach F, Schmidt SM et al (2008) The use of dendritic cells in cancer immunotherapy. Crit Rev Oncol Hematol 65:191-199
6. Aalamian M, Pirtskhalaishvili G, Nunez A et al (2001) Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46:68-75
7. Pirtskhalaishvili G, Shurin GV, Esche C et al (2000) Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer 83:506-513
8. Pirtskhalaishvili G, Shurin GV, Esche C et al (2001) TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis. Prostate Cancer Prostatic Dis 4:221-227
9. Laderach D, Movassagh M, Johnson A et al (2002) 4-1BB co-stimulation enhances human CD8(+) T cell priming by augment-ing the proliferation and survival of effector CD8(+) T cells. Int Immunol 14:1155-1167
10. Vinay DS, Kwon BS (1999) Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells. Cell Immunol 192:63-71
11. Gullo C, Koh LK, Pang WL et al (2010) Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling. PLoS One 5:e10845
12. Lin GH, Liu Y, Ambagala T et al (2010) Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice. PLoS One 5:e11003
13. Melero I, Shuford WW, Newby SA et al (1997) Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 3:682-685
14. Wilcox RA, Chapoval AI, Gorski KS et al (2002) Cutting edge: expression of functional CD137 receptor by dendritic cells. J Immunol 168:4262-4267
15. Nagaraj S, Pisarev V, Kinarsky L et al (2007) Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. J Immunother 30:169-179
16. Jähnisch H, Füssel S, Kiessling A et al (2010) Dendritic cell-based immunotherapy for prostate cancer. Clin Dev Immunol 2010:517493
17. Troy A, Davidson P, Atkinson C et al (1998) Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J Urol 160:214-219
18. Amdur RJ, Parsons JT, Fitzgerald LT et al (1990) The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. Int J Radiat Oncol Biol Phys 19:1377-1382
19. Futagawa T, Akiba H, Kodama T et al (2002) Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int Immunol 14:275-286
20. Lee SW, Park Y, So T et al (2008) Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol 9:917-926
21. Choi BK, Kim YH, Kwon PM et al (2009) 4-1BB functions as a survival factor in dendritic cells. J Immunol 182:4107-4115